Company name: PharmoCann Queensland Bauxite (Joint Venture)
Description: Operator of a joint venture incorporated to manufacture proprietary medical cannabis products in Australia for distribution throughout Australia and globally.
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: Medcan Australia and Pharmocann reached a definitive agreement to form a joint venture on October 18, 2018.
Number of active investors:
Profile last updated: 08-Jan-2020
Last known valuation:
Last known valuation date: